Literature DB >> 26438220

The Impact of Medical and Surgical Treatment for Benign Prostatic Hypertrophy on Erectile Function.

Gillian L Stearns1, Jaspreet S Sandhu2.   

Abstract

There is a well-known link between treatment for lower urinary tract symptoms (LUTS) and erectile dysfunction. Surgical and medical management of LUTS all have side effect profiles which may affect erectile dysfunction, ejaculatory dysfunction, or libido. These should be taken into consideration during patient counseling. This article reviews the common side effects of the medical and surgical treatments of LUTS.

Entities:  

Keywords:  Alpha blockers; Benign prostatic hypertrophy; Erectile dysfunction; Lower urinary tract symptoms; Phosphodiesterase-5 inhibitors; Retrograde ejaculation

Mesh：

Year:  2015        PMID： 26438220     DOI： 10.1007/s11934-015-0549-z

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  33 in total

1.  Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.

Authors:  Michael Marberger; Claus G Roehrborn; Leonard S Marks; Timothy Wilson; Roger S Rittmaster
Journal:  J Clin Endocrinol Metab       Date:  2006-01-24       Impact factor: 5.958

2.  Update on AUA guideline on the management of benign prostatic hyperplasia.

Authors:  Kevin T McVary; Claus G Roehrborn; Andrew L Avins; Michael J Barry; Reginald C Bruskewitz; Robert F Donnell; Harris E Foster; Chris M Gonzalez; Steven A Kaplan; David F Penson; James C Ulchaker; John T Wei
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

3.  Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting.

Authors:  Charalampos Mamoulakis; Andreas Skolarikos; Michael Schulze; Cesare M Scoffone; Jens J Rassweiler; Gerasimos Alivizatos; Roberto M Scarpa; Jean J M C H de la Rosette
Journal:  BJU Int       Date:  2013-03-12       Impact factor: 5.588

Review 4.  Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.

Authors:  Mauro Gacci; Vincenzo Ficarra; Arcangelo Sebastianelli; Giovanni Corona; Sergio Serni; Shahrokh F Shariat; Mario Maggi; Filiberto Zattoni; Marco Carini; Giacomo Novara
Journal:  J Sex Med       Date:  2014-04-07       Impact factor: 3.802

5.  High prevalence of benign prostatic hypertrophy in the community.

Authors:  W M Garraway; G N Collins; R J Lee
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

6.  Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.

Authors:  Ahmed Shelbaia; Wael M Elsaied; Hisham Elghamrawy; Ahmed Abdullah; Mohamed Salaheldin
Journal:  Urology       Date:  2013-05-25       Impact factor: 2.649

7.  Prospective, multidimensional evaluation of sexual disorders in men after laser photovaporization of the prostate.

Authors:  Jean-Baptiste Terrasa; Jean-Nicolas Cornu; François Haab; Olivier Cussenot; Bertrand Lukacs
Journal:  J Sex Med       Date:  2013-01-24       Impact factor: 3.802

8.  A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.

Authors:  Alexander Bachmann; Andrea Tubaro; Neil Barber; Frank d'Ancona; Gordon Muir; Ulrich Witzsch; Marc-Oliver Grimm; Joan Benejam; Jens-Uwe Stolzenburg; Antony Riddick; Sascha Pahernik; Herman Roelink; Filip Ameye; Christian Saussine; Franck Bruyère; Wolfgang Loidl; Tim Larner; Nirjan-Kumar Gogoi; Richard Hindley; Rolf Muschter; Andrew Thorpe; Nitin Shrotri; Stuart Graham; Moritz Hamann; Kurt Miller; Martin Schostak; Carlos Capitán; Helmut Knispel; J Andrew Thomas
Journal:  J Urol       Date:  2014-09-16       Impact factor: 7.450

9.  Impact of thulium VapoEnucleation of the prostate on erectile function: a prospective analysis of 72 patients at 12-month follow-up.

Authors:  Christian Tiburtius; Sophie Knipper; Andreas J Gross; Christopher Netsch
Journal:  Urology       Date:  2013-10-05       Impact factor: 2.649

10.  Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.

Authors:  Hunter Wessells; Johnny Roy; John Bannow; John Grayhack; Alvin M Matsumoto; Lisa Tenover; Richard Herlihy; William Fitch; Richard Labasky; Stephen Auerbach; Raul Parra; Jacob Rajfer; Jennifer Culbertson; Michael Lee; Mark A Bach; Joanne Waldstreicher
Journal:  Urology       Date:  2003-03       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.